Literature DB >> 27006255

Therapy: Risks associated with chronic PPI use - signal or noise?

Leila Kia1, Peter J Kahrilas1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27006255     DOI： 10.1038/nrgastro.2016.44

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  False alarms and pseudo-epidemics: the limitations of observational epidemiology.

Authors:  David A Grimes; Kenneth F Schulz
Journal:  Obstet Gynecol       Date:  2012-10       Impact factor: 7.661

2.  Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

Authors:  Benjamin Lazarus; Yuan Chen; Francis P Wilson; Yingying Sang; Alex R Chang; Josef Coresh; Morgan E Grams
Journal:  JAMA Intern Med       Date:  2016-02       Impact factor: 21.873

3.  Long-term proton pump inhibitor therapy and risk of hip fracture.

Authors:  Yu-Xiao Yang; James D Lewis; Solomon Epstein; David C Metz
Journal:  JAMA       Date:  2006-12-27       Impact factor: 56.272

4.  Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.

Authors:  Ala I Sharara; Jean M Chalhoub; Nijmeh Hammoud; Ali H Harb; Fayez S Sarkis; Ghassan Hamadeh
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-20       Impact factor: 11.382

5.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors:  Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

6.  Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.

Authors:  Willy Gomm; Klaus von Holt; Friederike Thomé; Karl Broich; Wolfgang Maier; Anne Fink; Gabriele Doblhammer; Britta Haenisch
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

Review 7.  Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.

Authors:  Allison A Lambert; Jennifer O Lam; Julie J Paik; Cesar Ugarte-Gil; M Bradley Drummond; Trevor A Crowell
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

8.  Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population.

Authors:  Nigam H Shah; Paea LePendu; Anna Bauer-Mehren; Yohannes T Ghebremariam; Srinivasan V Iyer; Jake Marcus; Kevin T Nead; John P Cooke; Nicholas J Leeper
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

9.  Proton pump inhibitors and acute kidney injury: a nested case-control study.

Authors:  Donald G Klepser; Dean S Collier; Gary L Cochran
Journal:  BMC Nephrol       Date:  2013-07-16       Impact factor: 2.388

10.  A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use.

Authors:  Mei-Ling Blank; Lianne Parkin; Charlotte Paul; Peter Herbison
Journal:  Kidney Int       Date:  2014-03-19       Impact factor: 10.612
  10 in total
  8 in total

Review 1.  ACG and CAG Clinical Guideline: Management of Dyspepsia.

Authors:  Paul Moayyedi; Brian E Lacy; Christopher N Andrews; Robert A Enns; Colin W Howden; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2017-06-20       Impact factor: 10.864

Review 2.  Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.

Authors:  C Prakash Gyawali
Journal:  Curr Gastroenterol Rep       Date:  2017-09

3.  Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

Authors:  Shobna J Bhatia; Govind K Makharia; Philip Abraham; Naresh Bhat; Ajay Kumar; D Nageshwar Reddy; Uday C Ghoshal; Vineet Ahuja; G Venkat Rao; Krishnadas Devadas; Amit K Dutta; Abhinav Jain; Saurabh Kedia; Rohit Dama; Rakesh Kalapala; Jose Filipe Alvares; Sunil Dadhich; Vinod Kumar Dixit; Mahesh Kumar Goenka; B D Goswami; Sanjeev K Issar; Venkatakrishnan Leelakrishnan; Mohandas K Mallath; Philip Mathew; Praveen Mathew; Subhashchandra Nandwani; Cannanore Ganesh Pai; Lorance Peter; A V Siva Prasad; Devinder Singh; Jaswinder Singh Sodhi; Randhir Sud; Jayanthi Venkataraman; Vandana Midha; Amol Bapaye; Usha Dutta; Ajay K Jain; Rakesh Kochhar; Amarender S Puri; Shivram Prasad Singh; Lalit Shimpi; Ajit Sood; Rajkumar T Wadhwa
Journal:  Indian J Gastroenterol       Date:  2019-12-05

4.  Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.

Authors:  E K Stern; D A Carlson; S Falmagne; A D Hoffmann; M Carns; J E Pandolfino; M Hinchcliff; D M Brenner
Journal:  Neurogastroenterol Motil       Date:  2017-11-06       Impact factor: 3.598

5.  When is proton pump inhibitor use appropriate?

Authors:  Rena Yadlapati; Peter J Kahrilas
Journal:  BMC Med       Date:  2017-02-21       Impact factor: 8.775

Review 6.  Emerging dilemmas in the diagnosis and management of gastroesophageal reflux disease.

Authors:  Peter Kahrilas; Rena Yadlapati; Sabine Roman
Journal:  F1000Res       Date:  2017-09-25

7.  Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.

Authors:  Nele Brusselaers; Jesper Lagergren
Journal:  BMJ Open       Date:  2018-07-07       Impact factor: 2.692

Review 8.  Chinese herbal medicine for functional dyspepsia: a network meta-analysis of prokinetic-controlled randomised trials.

Authors:  Leonard Ho; Claire C W Zhong; Charlene H L Wong; Justin C Y Wu; Karina K H Chan; Irene X Y Wu; Ting Hung Leung; Vincent C H Chung
Journal:  Chin Med       Date:  2021-12-20       Impact factor: 5.455
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.